The purpose of this research study is to evaluate the effects of HM15211 in people with NASH. This study will also evaluate study drug levels in your body and the time it takes your body to eliminate the drug (pharmacokinetics or PK) and what the study drug does to the body (pharmacodynamics or PD).

We are validating a revised questionnaire that looks at the quality of dying and death a patient experiences at end of life.

collect samples from patients with IBD

The study seeks to understand how the collaborative treatment approach helps to improve treatment for pregnant women. The goal of the research is to examine patient characteristics and the administration of care to gain a better understanding of the system-level strategies that lead to improved patient outcomes. To do this, the study uses surveys, focus groups, and case notes to examine the strategies utilized by the substance use network in Cabarrus County from the providers' and patients' perspective.

We are engaging 12 EMS providers throughout North Carolina in a focused training and education program meant to improve EMS pediatric care.

Diversity and inclusion offices use various communication strategies as part of their work to create a more welcoming and inclusive campus environment. This research involves interviewing diversity and inclusion professionals at universities in the Southeastern US to better understand their primary goals, decision-making processes, and communication efforts.

To collect and store specimens from people who have been exposed to a natural or manmade disaster.

Better understand symptoms that occur after liver-directed treatments for liver cancer

To provide a much-needed characterization of Lassa fever epidemiology and pathogenesis, and to determine the duration and infectivity of genital fluids from survivors that will provide a wellspring of data to inform public policy and individual care.

This study will evaluate the use of MMUD PBSC in adults and explore the safety and efficacy of MMUD BM in pediatric recipients with hematological malignancies who may lack other donor options.